Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMcAdam, LLC
Latest Disclosed Ownership1,222 shares
Latest Disclosed Value $ 430,112
McAdam, LLC reports 3.38% increase in ownership of AMGN / Amgen Inc.

On May 8, 2026 - McAdam, LLC filed a 13F-HR form disclosing ownership of 1,222 shares of Amgen Inc. (CH:AMGN) valued at $430,112 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,182 shares of Amgen Inc.. This represents a change in shares of 3.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMGEN COM 031162100 1,222 40 3.38 430 11.40 0.0194
2026-02-13 2025-12-31 13F AMGEN COM 031162100 1,182 9 0.77 387 16.62 0.0177
2025-10-29 2025-09-30 13F AMGEN COM 031162100 1,173 -221 -15.85 331 -14.91 0.0163
2025-07-15 2025-06-30 13F AMGEN COM 031162100 1,394 529 61.16 389 44.61 0.0213
2025-05-21 2025-03-31 13F AMGEN COM 031162100 865 9 1.05 270 20.63 0.0167
2025-01-24 2024-12-31 13F AMGEN COM 031162100 856 48 5.94 223 -14.23 0.0122
2024-10-22 2024-09-30 13F AMGEN COM 031162100 808 -2 -0.25 260 2.77 0.0146
2024-07-24 2024-06-30 13F AMGEN COM 031162100 810 60 8.00 253 18.78 0.0152
2024-04-23 2024-03-31 13F AMGEN COM 031162100 750 28 3.88 213 2.40 0.0137
2024-02-05 2023-12-31 13F AMGEN COM 031162100 722 722 208 0.0150
2023-10-31 2023-09-30 13F AMGEN COM 031162100 0 -1,592 -100.00 0 -100.00
2023-08-02 2023-06-30 13F AMGEN COM 031162100 1,592 1,592 353 0.0292
2019-01-30 2018-12-31 13F AMGEN COM 031162100 0 -353 -100.00 0 -100.00
2018-10-10 2018-09-30 13F AMGEN COM 031162100 353 0 0.00 73 12.31 0.0268
2018-08-22 2018-06-30 13F AMGEN COM 031162100 353 33 10.31 65 18.18 0.0265
2018-04-24 2018-03-31 13F AMGEN COM 031162100 320 320 55 0.0253
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.